Skip to main content
Toggle navigation
Search
Home
Conference Program
Tweets by 2023 ASAM Annual Conference
Home
Poster Schedule
All Days
Fri, Apr 14
Sat, Apr 15
Poster Schedule
Type here to filter the list
Friday, April 14, 2023
11:45 AM – 1:15 PM
(1) Healthcare Utilization for Substance Use Disorder related invasive infections
Favorite
11:45 AM – 1:15 PM
(2) Evaluation of an Emergency Resident Curriculum on Medication for Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(3) Impact of a Medication for Opioid Use Disorder Curriculum for Emergency Residents
Favorite
11:45 AM – 1:15 PM
(4) First Responder Experiences with a Novel Naloxone Leave-Behind Program
Favorite
11:45 AM – 1:15 PM
(5) Last Negative: Testing Intervals in People who Inject Drugs with Incident HIV
Favorite
11:45 AM – 1:15 PM
(6) An Integrated Model of HIV Primary Care and Substance Use Treatment
Favorite
11:45 AM – 1:15 PM
(7) Integrating MOUD and HIV PrEP for Adolescents and Young Adults
Favorite
11:45 AM – 1:15 PM
(8) Expanded Methadone Take-Home Use Lowered Methadone-Related Deaths in Black and Hispanic Men
Favorite
11:45 AM – 1:15 PM
(9) Healthcare Experiences of REACH Medical Outreach Patients in Ithaca, NY during COVID-19
Favorite
11:45 AM – 1:15 PM
(10) How Women in Recovery Navigate Pregnancy, Postpartum, and Early Motherhood
Favorite
11:45 AM – 1:15 PM
(11) Missed Opportunities to Support Resilience Among Pregnant People with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(12) Obstetric Clinician Perspectives on the Utility of Toxicology Testing During Pregnancy
Favorite
11:45 AM – 1:15 PM
(13) Survey Assessment of Cannabis Use in an Obstetrics and Gynecology Clinic
Favorite
11:45 AM – 1:15 PM
(14) Drug Testing Interpretation in the Peripartum Setting: Results of Clinician Survey
Favorite
11:45 AM – 1:15 PM
(15) Inpatient Providers’ Attitudes & Clinical Practices surrounding Harm Reduction Services
Favorite
11:45 AM – 1:15 PM
(16) testRI: Communicating Changes in the Rhode Island Local Drug Supply
Favorite
11:45 AM – 1:15 PM
(17) Improving Medical Students' Attitudes toward Addiction through a Stigma Teaching Session
Favorite
11:45 AM – 1:15 PM
(18) Increasing Access to Same-Day Addiction Services in Primary Care Clinics Among Veterans
Favorite
11:45 AM – 1:15 PM
(19) Stimulant Use and Adverse Outcomes in Hospitalized People Using Opioids with Infections
Favorite
11:45 AM – 1:15 PM
(20) Enhancing Future Healthcare Professional Education Surrounding Substance Use Disorders
Favorite
11:45 AM – 1:15 PM
(21) An Initiative to Improve Evidence-Based Nicotine Prescribing in the Primary Care Setting
Favorite
11:45 AM – 1:15 PM
(22) Mind the Gap: Telemedicine Effectively Bridges Patients with OUD to Treatment
Favorite
11:45 AM – 1:15 PM
(23) REDO: Connecting Individuals to Care Post-ED
Favorite
11:45 AM – 1:15 PM
(24) Effects after Self-Administration of Typical Kratom Dose among Regular Kratom-Using Adults
Favorite
11:45 AM – 1:15 PM
(25) Exploring Correlates of Self-Stigma in Persons who use Methamphetamine
Favorite
11:45 AM – 1:15 PM
(26) MiRA1a, a Novel Synthetic THC Analog that Improves Cognition
Favorite
11:45 AM – 1:15 PM
(27) Pharmacological Evaluation of the Ghrelin System as a Target for Binge Drinking
Favorite
11:45 AM – 1:15 PM
(28) Cognitive, Imaging, and Psychiatric Changes Associated with Chronic Toluene Use
Favorite
11:45 AM – 1:15 PM
(29) Major Depressive Disorder Prolongs Hospital Stay Among Patients with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(30) Psychiatric Illness and Intentional Overdose Associated with Suicide Risk in OUD Patients
Favorite
11:45 AM – 1:15 PM
(31) The Past is Never Past: Childhood Trauma Influences Current OUD Severity
Favorite
11:45 AM – 1:15 PM
(32) A Simulation Curriculum to Improve Care of Patients with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(33) Bright Spot Communities: Community-Level Protective Factors to Improve Opioid Outcomes
Favorite
11:45 AM – 1:15 PM
(34) Evaluating the Feasibility and Acceptability of ED-Distributed Fentanyl Test Strips
Favorite
11:45 AM – 1:15 PM
(35) Fentanyl Use in a Pediatric Addiction Clinic – A Retrospective Review
Favorite
11:45 AM – 1:15 PM
(36) Immediate Fentanyl to Extended Release Buprenorphine Transition in Two Adolescents with OUD
Favorite
11:45 AM – 1:15 PM
(37) MOUD Treatment Performance Measures Implemented among Providers in Pennsylvania
Favorite
11:45 AM – 1:15 PM
(38) Opioid and Benzodiazepine Utilization Patterns in Metropolitan and Rural Texas
Favorite
11:45 AM – 1:15 PM
(39) Retention in Telehealth Treatment for Opioid Use Disorder among Rural Populations
Favorite
11:45 AM – 1:15 PM
(40) Race and Mental Health among Adults with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(41) Single Versus Divided Methadone Dosing for Pain Treatment in Persons with OUD
Favorite
11:45 AM – 1:15 PM
(42) A Case of Ocular Buprenorphine Use
Favorite
11:45 AM – 1:15 PM
(43) Development of an Inpatient Protocol for Pain Management of Buprenorphine Patients
Favorite
11:45 AM – 1:15 PM
(44) Pain Management for Patients on Buprenorphine Undergoing Valve Repair Surgery for DUA-IE.
Favorite
11:45 AM – 1:15 PM
(45) Precipitated Withdrawal Refractory to High-Dose Buprenorphine: A Cautionary Tale
Favorite
11:45 AM – 1:15 PM
(46) START: A Program to Spread Buprenorphine Initiation During Hospitalization in Texas
Favorite
11:45 AM – 1:15 PM
(47) Wound Care Uptake among Clients at a Low-Threshold, Mobile Buprenorphine Service
Favorite
11:45 AM – 1:15 PM
(48) Application of the ARIMA Model to Forecast Future Overdose Deaths
Favorite
11:45 AM – 1:15 PM
(49) Bacillus Cereus Panophthalmitis: A Rare Complication of Injection Drug Use
Favorite
11:45 AM – 1:15 PM
(50) Service Utilization in Addiction Treatment across In-Person, Telehealth, and Hybrid Models
Favorite
11:45 AM – 1:15 PM
(51) Social Support in Patients Receiving Buprenorphine Treatment via a Peer-Navigator Program
Favorite
Saturday, April 15, 2023
11:45 AM – 1:15 PM
(53) Opioid and Benzodiazepine Co-Prescribing at Emergency Department Discharge from 2012-2019
Favorite
11:45 AM – 1:15 PM
(54) Social Determinants of Health and Insomnia in People Receiving Buprenorphine for OUD
Favorite
11:45 AM – 1:15 PM
(55) Effect of Student-Led Community Workshops on Knowledge and Attitudes About Opioid Overdose
Favorite
11:45 AM – 1:15 PM
(56) Destruction by Designer Benzodiazepines: A Case Report
Favorite
11:45 AM – 1:15 PM
(57) Alcohol Withdrawal and Benzodiazepine Use in an Acute Inpatient Rural Hospital
Favorite
11:45 AM – 1:15 PM
(58) Consequences of Benzodiazepine-Induced Neurological Dysfunction: An Internet Survey
Favorite
11:45 AM – 1:15 PM
(59) Characterizing the Contribution of Alcohol Use towards Distinct Neurocognitive Profiles
Favorite
11:45 AM – 1:15 PM
(60) Improving Well Childcare, Newborn and Maternal Outcomes with COMPASSION Model
Favorite
11:45 AM – 1:15 PM
(61) Therapeutic Pathways for Children Affected by Caregiver Substance Misuse
Favorite
11:45 AM – 1:15 PM
(62) Improving Substance Use Screening using S2BI in a Pediatric Primary Care Clinic
Favorite
11:45 AM – 1:15 PM
(63) Disparities in Toxicology Testing Results During the Birthing Hospitalization
Favorite
11:45 AM – 1:15 PM
(64) Assessing Barriers to Primary Care for Reproductive-Aged Women with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(65) A Multi-level Analysis of MOUD Use Among Pregnant Individuals in Treatment
Favorite
11:45 AM – 1:15 PM
(66) Fentanyl Fat Sequestration in Pregnancy and Post-Pregnancy Urine Drug Test Results
Favorite
11:45 AM – 1:15 PM
(67) Put a Patch on and See What Happens: Harm Reduction for TUD
Favorite
11:45 AM – 1:15 PM
(68) Addressing Tobacco Use Disorder in SUD Treatment: Talking about Tobacco
Favorite
11:45 AM – 1:15 PM
(69) Social Media for Smoking Cessation among Adult Smokers in the United States
Favorite
11:45 AM – 1:15 PM
(70) Bridging Patient and Physician Perspectives on Addiction Recovery and Spirituality
Favorite
11:45 AM – 1:15 PM
(71) Community Pharmacists’ Attitudes toward and Practice of Pharmacy-Based Harm Reduction
Favorite
11:45 AM – 1:15 PM
(72) Healthcare Attitudes on Reporting Impaired Colleagues
Favorite
11:45 AM – 1:15 PM
(73) Substance Use and Mental Health Among Middle- and High-Schoolers: A Survey Study
Favorite
11:45 AM – 1:15 PM
(74) Evaluating a Pre-Arrest Diversion Program: Who Benefits and Does it Work?
Favorite
11:45 AM – 1:15 PM
(75) Barriers to Recovery Following an Overdose: A Qualitative Study
Favorite
11:45 AM – 1:15 PM
(76) Evaluating Admissions for Opioid and Substance Use Disorders under Michigan’s Opioid Laws
Favorite
11:45 AM – 1:15 PM
(77) Assessing Inpatient Dispositions of Opioid and Polysubstance Use Under Michigan Opioid Laws
Favorite
11:45 AM – 1:15 PM
(78) Acute Opioid Withdrawal after Liposuction in a Patient on Extended Release Buprenorphine
Favorite
11:45 AM – 1:15 PM
(79) Buprenorphine/Naloxone Induction of OUD Patients Using Telehealth in the Fentanyl Era
Favorite
11:45 AM – 1:15 PM
(80) Comparison of a Hospital-Based 3, 5, and 7-Day Buprenorphine Microinduction Protocol
Favorite
11:45 AM – 1:15 PM
(81) Examination of Patient Reported Buprenorphine Dosing in Patients with Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(82) Feasibility of Microdose Buprenorphine Starts with Methadone and Illicit Opioid Use
Favorite
11:45 AM – 1:15 PM
(83) Israel's First Low-Dose Buprenorphine Inductions for Fentanyl, Oxycodone and Tramadol Use
Favorite
11:45 AM – 1:15 PM
(84) Patient Related Factors behind Racial Inequities of Buprenorphine Treatment in Primary Care
Favorite
11:45 AM – 1:15 PM
(85) Rapid Methadone Induction in the Hospital Setting: A Retrospective Observational Analysis
Favorite
11:45 AM – 1:15 PM
(86) XR-BUP in the Colorado Department of Corrections (CDOC): Lessons from >500 injections
Favorite
11:45 AM – 1:15 PM
(87) A Qualitative Study on the Trajectories of People with OUD after Incarceration
Favorite
11:45 AM – 1:15 PM
(88) A Multidisciplinary Approach for OUD among Justice Involved Individuals in Rural Settings
Favorite
11:45 AM – 1:15 PM
(89) A Quality Improvement Initiative: Embedding OUD treatment in academic primary care
Favorite
11:45 AM – 1:15 PM
(90) Effects of Opioid and Stimulant Use Disorders on COVID-19 Reinfection and Outcomes
Favorite
11:45 AM – 1:15 PM
(91) Insomnia is Associated with Neurofunctional Differences among Females Treated for OUD
Favorite
11:45 AM – 1:15 PM
(92) Patient-Directed Discharges are Associated with Poor Health Outcomes in Opioid Use Disorder
Favorite
11:45 AM – 1:15 PM
(93) Patients' Illness Models Influence Their Beliefs in Opioid Use Disorder Treatment Efficacy
Favorite
11:45 AM – 1:15 PM
(94) Stress Among Persons with Opioid Use Disorder during the First Year Postpartum
Favorite
11:45 AM – 1:15 PM
(95) Qualitative Analysis of Reasons Why Patients Decline ASAM Levels of Care
Favorite
11:45 AM – 1:15 PM
(96) Emergency Department Buprenorphine-Naloxone for Non-Fatal Opioid Overdose Survivors
Favorite
11:45 AM – 1:15 PM
(97) Binge Drinking, Intimate Partner Violence, and Sex in Transgender Population in China
Favorite
11:45 AM – 1:15 PM
(98) Oral Antibiotic Prescription for Persons Who Use Drugs Pursuing Patient-Directed Discharge
Favorite
11:45 AM – 1:15 PM
(99) Pharmacological Cognitive Enhancement: Perceptions of Stimulant Misuse and Integrity
Favorite
11:45 AM – 1:15 PM
(100) The Ecological Validity of the Yale Food Addiction Scale 2.0
Favorite
11:45 AM – 1:15 PM
(101) Treated Me like a Junkie: Factors Associated with Harm Reduction among PWID
Favorite
11:45 AM – 1:15 PM
(102) Validation of Online Version of Addiction Severity Index-6 in Chilean Population
Favorite
11:45 AM – 1:15 PM
(103) Impact of Co-occurring Substance Use Disorder on Inpatient Adolescent Psychiatry Outcomes
Favorite
Back to Top
